# A Prospective Open-label Study of Aripiprazole in Fragile X Syndrome

> **NCT00420459** · PHASE2 · COMPLETED · sponsor: **Indiana University** · enrollment: 12 (actual)

## Conditions studied

- Fragile X Syndrome

## Interventions

- **DRUG:** Aripiprazole

## Key facts

- **NCT ID:** NCT00420459
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00420459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00420459, "A Prospective Open-label Study of Aripiprazole in Fragile X Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00420459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*